Fu‐Gang Zhu - Concepedia

Author

Fu‐Gang Zhu

Idera Pharmaceuticals (United States)

Also Known As

FU‐GANG ZHU, Fu-Gang Zhu, FuGang Zhu, Fugang Zhu, Fu‐Gang Zhu

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Idera Pharmaceuticals (United States)Duke University Hospital Duke Medical Center Dalhousie University Everbright International (China)

About

Fu‐Gang Zhu is an author at Idera Pharmaceuticals (United States) specializing in immunology, medicine, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	651
2	Allergy	6	6	218
3	Engineering	1	1	25
4	Natural Sciences	1	1	46
5	Allergy Medicine	1	1	62

Fu‐Gang Zhu

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Prostaglandin E2 Selectively Enhances the IgE-Mediated Production of IL-6 and Granulocyte-Macrophage Colony-Stimulating Factor by Mast Cells Through an EP1/EP3-Dependent Mechanism Kaede Gomi, Fu‐Gang Zhu, Jean S. Marshall The Journal of Immunology	2000	98
A Toll-Like Receptor 7, 8, and 9 Antagonist Inhibits Th1 and Th17 Responses and Inflammasome Activation in a Model of IL-23-Induced Psoriasis Weiwen Jiang, Fu‐Gang Zhu, Lakshmi Bhagat, Journal of Investigative Dermatology	2013	87
The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides Fu‐Gang Zhu, Charles F. Reich, David S. Pisetsky Immunology	2001	79
Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8 Tao Lan, Ekambar R. Kandimalla, Dong Soo Yu, Proceedings of the National Academy of Sciences Simra CompoundsInnate Immune SystemImmunologyHuman Tlr7Innate Immunity	2007	74
Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy Daqing Wang, Wayne Jiang, Fu‐Gang Zhu, International Journal of Oncology ImmunologyImmune RegulationImmunoeditingImmunotherapeuticsCd4 T Cell Responses	2018	64
Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice Fu‐Gang Zhu, Ekambar R. Kandimalla, Dong Yu, Journal of Allergy and Clinical Immunology InflammationFood AllergyToll-like Receptor 9AllergySynthetic Agonist	2007	62
Modifications Incorporated in CpG Motifs of Oligodeoxynucleotides Lead to Antagonist Activity of Toll-like Receptors 7 and 9 Dong Soo Yu, Daqing Wang, Fu‐Gang Zhu, Journal of Medicinal Chemistry ImmunologyImmune RegulationMolecular BiologyImmunologic MechanismModified Odns	2009	62
A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif Ekambar R. Kandimalla, Lakshmi Bhagat, Fu‐Gang Zhu, Proceedings of the National Academy of Sciences	2003	60
A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice Fu‐Gang Zhu, Weiwen Jiang, Lakshmi Bhagat, Autoimmunity Renal PathologyImmunologyPathologyNovel AntagonistImmune Dysregulation	2013	59
CpG-containing oligodeoxynucleotides induce TNF-α and IL-6 production but not degranulation from murine bone marrow-derived mast cells Fu‐Gang Zhu, Jean S. Marshall Journal of Leukocyte Biology Mast Cell DisorderImmunodeficienciesImmune RegulationImmunologyCell Death	2001	47

Page 1